234 related articles for article (PubMed ID: 17178196)
1. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.
Marchalant Y; Rosi S; Wenk GL
Neuroscience; 2007 Feb; 144(4):1516-22. PubMed ID: 17178196
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis.
Marchalant Y; Brothers HM; Norman GJ; Karelina K; DeVries AC; Wenk GL
Neurobiol Dis; 2009 May; 34(2):300-7. PubMed ID: 19385063
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
5. The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling.
Du JJ; Liu ZQ; Yan Y; Xiong J; Jia XT; Di ZL; Ren JJ
J Mol Neurosci; 2020 Mar; 70(3):422-432. PubMed ID: 31732924
[TBL] [Abstract][Full Text] [Related]
6. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
7. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
8. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat.
Rosi S; Vazdarjanova A; Ramirez-Amaya V; Worley PF; Barnes CA; Wenk GL
Neuroscience; 2006 Nov; 142(4):1303-15. PubMed ID: 16989956
[TBL] [Abstract][Full Text] [Related]
9. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
Rawls SM; Cabassa J; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
[TBL] [Abstract][Full Text] [Related]
12. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
Alén F; Santos A; Moreno-Sanz G; González-Cuevas G; Giné E; Franco-Ruiz L; Navarro M; López-Moreno JA
Neuroscience; 2009 Jan; 158(2):465-73. PubMed ID: 18977415
[TBL] [Abstract][Full Text] [Related]
14. The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia.
Wang DP; Yin H; Kang K; Lin Q; Su SH; Hai J
Psychiatry Res; 2018 Sep; 267():281-288. PubMed ID: 29945070
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
16. Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist.
Morita K; Kamei J
Eur J Pharmacol; 2003 Aug; 474(2-3):269-72. PubMed ID: 12921873
[TBL] [Abstract][Full Text] [Related]
17. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2008 May; 325(2):641-5. PubMed ID: 18281594
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
Su SH; Wang YQ; Wu YF; Wang DP; Lin Q; Hai J
Behav Brain Res; 2016 Oct; 313():334-344. PubMed ID: 27424778
[TBL] [Abstract][Full Text] [Related]
19. Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist.
Dableh LJ; Yashpal K; Henry JL
Eur J Pharmacol; 2009 Jan; 602(1):36-40. PubMed ID: 19027734
[TBL] [Abstract][Full Text] [Related]
20. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.
Fernández-López D; Faustino J; Derugin N; Wendland M; Lizasoain I; Moro MA; Vexler ZS
Neuroscience; 2012 Apr; 207():307-15. PubMed ID: 22285309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
